Clinical Trial

A Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study is a randomized, double-blind, placebo-controlled, dose-escalation phase I clinical trial. This study consists of two parts: the single-dose escalation study (SAD) in healthy subjects and the multiple-dose escalation study (MAD) in obese patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-01.
Status change: Not Yet Recruiting → Recruiting 2026-05-12
Trial Details
NCT Number NCT07280936
Lead Sponsor Beijing Suncadia Pharmaceuticals Co., Ltd
Conditions Obesity, Overweight
Enrollment 124 participants
Start Date 2026-01-05
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-14